See also this year's filing and all EDGAR filings for this company.
PDF Report 0001822462_2023_Foghorn_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001822462, Foghorn Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 351,399,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 53,484,000 |
| 4 | LiabilitiesCurrent | 55,205,000 |
| 5 | LiabilitiesNoncurrent | 349,566,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 30,747,000 |
| 9 | ResearchAndDevelopmentExpense | 105,618,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 19,228,000 |
| 12 | remainder_NetIncome | 8,255,000 |
| 13 | remainder_ComprehensiveNetIncome | -3,976,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 404,883,000 |
| 1 | Liabilities | 404,771,000 |
| 2 | Expenses | 136,365,000 |
| 3 | Revenues | 19,228,000 |
| 4 | StockholdersEquity | 112,000 |
| 5 | NetIncome | -108,882,000 |
| 6 | ComprehensiveNetIncome | -110,870,000 |
| 7 | BaseVar | 488,739,000 |
| 8 | EconomicCapitalRatio | -0.273 |
Edgar->Model Mapping
Feature Distribution
Change over Time
